Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of IVIg on Endothelial Function in CVID
NCT03534479Completed
- Sponsor
- University of Naples Federico II
- Start
- Apr 2010
- Primary completion
- Apr 2013
- Countries
- 1
01
Overview
Open-label, single-arm trial in common variable immunodeficiency (CVID), sponsored by University of Naples Federico II. Primary endpoint: Flow Mediated Dilation at 3 weeks. Started Apr 2010; status: completed.
02
Conditions
common variable immunodeficiency (CVID)
Beyond the preview
Go deeper on NCT03534479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534479.